Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence

References

• Albalawi F, Hussein MZ, Fakurazi S, et al. Engineered nanomaterials: the challenges and opportunities for nanomedicines. Int J Nanomedicine. 2021 [cited 2021 Dec 20];16:161–184. doi: 10.2147/IJN.S288236.
   PubMed Web of Science ®Google Scholar
• Castro de KC, Costa JM, Campos MGN. Drug-loaded polymeric nanoparticles: a review. Int J Polym Mater Polym Biomater. 2020 [cited 2021 Oct 8];1–13. doi: 10.1080/00914037.2020.1798436.
   Web of Science ®Google Scholar
• Liu Y, Yang G, Jin S, et al. Development of high-drug-loading nanoparticles. ChemPlusChem. 2020 [cited 2021 Dec 6];85(9):2143–2157 doi:10.1002/cplu.202000496
   PubMed Web of Science ®Google Scholar
• Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. Pharm Ther. 2017 [cited 2021 Dec 11];42:742–755. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720487/
   Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011 [cited 2021 Oct 14];63(3):170–183 doi:10.1016/j.addr.2010.10.008.
   PubMed Web of Science ®Google Scholar
• Bobo D, Robinson KJ, Islam J, et al. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016 [cited 2021 Oct 8];33(10):2373–2387 doi:10.1007/s11095-016-1958-5.
   PubMed Web of Science ®Google Scholar
• Kang H, Rho S, Stiles WR, et al. Size-dependent EPR effect of polymeric nanoparticles on tumor targeting. Adv Healthc Mater. 2020 [cited 2021 Oct 14];9(1):1901223 doi:10.1002/adhm.201901223
   Web of Science ®Google Scholar
• Matsumura Y, Maeda H, New A. Concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986 [cited 2021 Dec 17];46:6387–6392. Available from https://cancerres.aacrjournals.org/content/46/12_Part_1/6387
   PubMed Web of Science ®Google Scholar
• Sun D, Zhou S, Gao W. What went wrong with anticancer nanomedicine design and how to make it right. ACS Nano. 2020 [cited 2022 Jan 20];14(10):12281–12290 doi:10.1021/acsnano.9b09713.
   PubMed Web of Science ®Google Scholar
• Hare JI, Lammers T, Ashford MB, et al. Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev. 2017 [cited 2021 Dec 8];108:25–38. doi: 10.1016/j.addr.2016.04.025
   PubMed Web of Science ®Google Scholar
• Etheridge ML, Campbell SA, Erdman AG, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomed Nanotechnol Biol Med. 2013 [cited 2021 Dec 18];9(1):1–14 doi:10.1016/j.nano.2012.05.013
   PubMed Web of Science ®Google Scholar
• Lopez-Cantu DO, Wang X, Carrasco-Magallanes H, et al. From bench to the clinic: the path to translation of nanotechnology-enabled mRNA SARS-CoV-2 vaccines. Nano-Micro Lett. 2022 [cited 2022 Jul 16];14(1):41 doi:10.1007/s40820-021-00771-8.
   PubMed Web of Science ®Google Scholar
• Roser M, Ortiz-Ospina E. COVID-19 vaccine doses administered by manufacturer [Internet]. Our World Data. cited 2022 May 10 Available from. https://ourworldindata.org/grapher/covid-vaccine-doses-by-manufacturer
   Google Scholar
• Varahachalam SP, Lahooti B, Chamaneh M, et al. Nanomedicine for the SARS-CoV-2: state-of-the-Art and Future Prospects. Int J Nanomedicine. 2021 [cited 2022 Jul 15];16:539–560. doi: 10.2147/IJN.S283686.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kong N, Zhang X, et al. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020 [cited 2022 Jul 16];5(11):847–860 doi:10.1038/s41578-020-00247-y
   PubMed Web of Science ®Google Scholar
• Tang Z, Zhang X, Shu Y, et al. Insights from nanotechnology in COVID-19 treatment. Nano Today. 2021 [cited 2022 Jul 16];36:101019. doi: 10.1016/j.nantod.2020.101019
   PubMed Web of Science ®Google Scholar
• Wang X, Hu T, Hu B, et al. Imparting reusable and SARS-CoV-2 inhibition properties to standard masks through metal-organic nanocoatings. J Hazard Mater. 2022 [cited 2022 Jul 16];431:128441. doi: 10.1016/j.jhazmat.2022.128441
   PubMed Web of Science ®Google Scholar
• Farjadian F, Ghasemi A, Gohari O, et al. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomed. 2019 [cited 2022 Mar 14];14(1):93–126 doi:10.2217/nnm-2018-0120
   PubMed Web of Science ®Google Scholar
• Global Industry Analysts, Inc. Healthcare nanotechnology (Nanomedicine) - global market trajectory & analytics [Internet]. 2021. [cited 2022 Jan 2]. Available from: https://www.researchandmarkets.com/reports/5030234/healthcare-nanotechnology-nanomedicine-global.
   Google Scholar
• Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019 [cited 2021 Oct 8];4(3):e10143 doi:10.1002/btm2.10143.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 [cited 2021 Dec 1];20(2):101–124 doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Siepmann J, Faham A, Clas S-D, et al. Lipids and polymers in pharmaceutical technology: lifelong companions. Int J Pharm. 2019 [cited 2021 Dec 12];558:128–142. doi: 10.1016/j.ijpharm.2018.12.080
   PubMedGoogle Scholar
• Tenchov R, Bird R, Curtze AE, et al. Lipid nanoparticles─from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021 [cited 2022 Jan 19];15(11):16982–17015 doi:10.1021/acsnano.1c04996.
   PubMed Web of Science ®Google Scholar
• Pharmacoeconomic review report: patisiran (Onpattro): (Alnylam Netherlands B.V.): indication: treatment of polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 [cited 2021 Dec 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK549694/.
   Google Scholar
• Dyer O. Covid-19: countries are learning what others paid for vaccines. BMJ. 2021 [cited 2021 Dec 14];372:n281. doi: 10.1136/bmj.n281
   PubMed Web of Science ®Google Scholar
• Wang W, Ye Z, Gao H, et al. Computational pharmaceutics - A new paradigm of drug delivery. J Control Release. 2021 [cited 2022 Mar 16];338:119–136. doi: 10.1016/j.jconrel.2021.08.030
   PubMed Web of Science ®Google Scholar
• Leroux J. Editorial: drug delivery: too much complexity, not enough reproducibility? Angew Chem Int Ed. 2017 [cited 2021 Dec 9];56(48):15170–15171 doi:10.1002/anie.201709002.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Duda GN, Grainger DW, et al. Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation. Adv Drug Deliv Rev. 2022 [cited 2022 Feb 24];182:114118. doi: 10.1016/j.addr.2022.114118.
   PubMedGoogle Scholar
• Lammers T, Storm G. Setting standards to promote progress in bio–nano science. Nat Nanotechnol. 2019 [cited 2021 Dec 8];14(7):626 doi:10.1038/s41565-019-0497-8.
   PubMed Web of Science ®Google Scholar
• Steiner S, Wolf J, Glatzel S, et al. Organic synthesis in a modular robotic system driven by a chemical programming language. Science. 2019 [cited 2022 Mar 13];363(6423):eaav2211 doi:10.1126/science.aav2211
   PubMed Web of Science ®Google Scholar
• Stokes JM, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery. Cell. 2020 [cited 2022 Mar 13;]180(4):688–702.e13 doi:10.1016/j.cell.2020.01.021
   PubMed Web of Science ®Google Scholar
• Yang Y, Ye Z, Su Y, et al. Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharm Sin B. 2019 [cited 2021 Dec 22];9(1):177–185 doi:10.1016/j.apsb.2018.09.010
   PubMed Web of Science ®Google Scholar
• Operti MC, Bernhardt A, Grimm S, et al. PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharm. 2021 [cited 2021 Oct 26];605:120807. doi: 10.1016/j.ijpharm.2021.120807
   PubMed Web of Science ®Google Scholar
• Ghitman J, Biru EI, Stan R, et al. Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine. Mater Des. 2020 [cited 2021 Dec 22];193:108805. doi: 10.1016/j.matdes.2020.108805
   Web of Science ®Google Scholar
• Kumar JN, Li Q, Jun Y. Challenges and opportunities of polymer design with machine learning and high throughput experimentation. MRS Commun. 2019 [cited 2021 Dec 14];9(2):537–544 doi:10.1557/mrc.2019.54.
   Web of Science ®Google Scholar
• Sharma S, Parmar A, Kori S, et al. PLGA-based nanoparticles: a new paradigm in biomedical applications. TRAC-Trends Anal Chem. 2016 [cited 2022 Mar 4];80:30–40. doi: 10.1016/j.trac.2015.06.014
   Web of Science ®Google Scholar
• Choi J-S, Park J-S. Design and evaluation of the anticancer activity of paclitaxel-loaded anisotropic-poly(lactic-co-glycolic acid) nanoparticles with PEGylated chitosan surface modifications. Int J Biol Macromol. 2020 [cited 2021 Dec 15];162:1064–1075. doi: 10.1016/j.ijbiomac.2020.06.237
   PubMed Web of Science ®Google Scholar
• Luiz MT, Abriata JP, Raspantini GL, et al. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Mater Sci Eng C. 2019 [cited 2021 Dec 15];105:110038. doi: 10.1016/j.msec.2019.110038
   PubMed Web of Science ®Google Scholar
• Kou L, Hou Y, Yao Q, et al. L-Carnitine-conjugated nanoparticles to promote permeation across blood–brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2. Artif Cells Nanomed Biotechnol. 2018 [cited 2021 Dec 23];46:1605–1616. doi: 10.1080/21691401.2017.1384385
   PubMed Web of Science ®Google Scholar
• Jeevarathinam AS, Lemaster JE, Chen F, et al. Photoacoustic imaging quantifies drug release from nanocarriers via redox chemistry of dye-labeled cargo. Angew Chem Int Ed Engl. 2020 [cited 2021 Dec 15];59(12):4678–4683 doi:10.1002/anie.201914120
   PubMed Web of Science ®Google Scholar
• Duan T, Xu Z, Sun F, et al. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. Biomed Pharmacother. 2019 [cited 2021 Dec 15];117:109121. doi: 10.1016/j.biopha.2019.109121
   PubMed Web of Science ®Google Scholar
• Cerqueira BBS, Lasham A, Shelling AN, et al. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Mater Sci Eng C. 2017 [cited 2022 Mar 3];76:593–600. doi: 10.1016/j.msec.2017.03.121
   PubMed Web of Science ®Google Scholar
• Thi TTH, Suys EJA, Lee JS, et al. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 Vaccines. Vaccines. 2021 [cited 2022 Feb 2];9(4):359 doi:10.3390/vaccines9040359
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017 [cited 2022 Feb 2];9(4):12 doi:10.3390/pharmaceutics9020012
   PubMed Web of Science ®Google Scholar
• Carrasco MJ, Alishetty S, Alameh M-G, et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol. 2021 [cited 2022 Apr 23];4(1):1–15 doi:10.1038/s42003-021-02441-2
   PubMed Web of Science ®Google Scholar
• Baptista B, Carapito R, Laroui N, et al. mRNA, a revolution in biomedicine. Pharmaceutics. 2021 [cited 2022 Apr 23];13(12):2090 doi:10.3390/pharmaceutics13122090
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. Nanoparticles in the clinic. Bioeng Transl Med. 2016 [cited 2021 Oct 8];1(1):10–29 doi:10.1002/btm2.10003.
   PubMed Web of Science ®Google Scholar
• Merle P, Blanc J-F, Phelip J-M, et al. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2019 [cited 2022 Jan 22];4(6):454–465 doi:10.1016/S2468-1253(19)30040-8.
   PubMed Web of Science ®Google Scholar
• Hou X, Zaks T, Langer R, et al. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021 [cited 2021 Oct 28];1–17 . https://www.nature.com/articles/s41578-021-00358-0
   Web of Science ®Google Scholar
• Christensen M, Yunker LPE, Shiri P, et al. Automation isn’t automatic. Chem Sci. 2021 [cited 2021 Dec 7]; 12(47):15473–15490 doi:10.1039/D1SC04588A.
   PubMed Web of Science ®Google Scholar
• Egorov E, Pieters C, Korach-Rechtman H, et al. Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems. Drug Deliv Transl Res. 2021 [cited 2021 Dec 6];11(2):345–352 doi:10.1007/s13346-021-00929-2.
   PubMed Web of Science ®Google Scholar
• Kong F, Yuan L, Zheng YF, et al. Automatic liquid handling for life science: a critical review of the current state of the Art. J Lab Autom. 2012 [cited 2022 Jan 20];17(3):169–185 doi:10.1177/2211068211435302.
   PubMedGoogle Scholar
• Lehmann R, Severitt JC, Roddelkopf T, et al. Biomek cell workstation: a variable system for automated cell cultivation. J Lab Autom. 2016 [cited 2022 Jan 20];21(3):439–450. doi: 10.1177/2211068215599786
   PubMedGoogle Scholar
• Shiri P, Lai V, Zepel T, et al. Automated solubility screening platform using computer vision. iScience. 2021 [cited 2022 Sep 29];24(3):102176 doi:10.1016/j.isci.2021.102176
   PubMed Web of Science ®Google Scholar
• Eppel S, Xu H, Ru Wang Y, et al. Predicting 3D shapes, masks, and properties of materials inside transparent containers, using the TransProteus CGI dataset. Digit Discov. 2022 [cited 2022 Sep 29];1(1):45–60 doi:10.1039/D1DD00014D.
   Google Scholar
• Fan Y, Yen C-W, Lin H-C, et al. Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles. Int J Pharm. 2021 [cited 2021 Sep 2];599:120392. doi: 10.1016/j.ijpharm.2021.120392
   PubMed Web of Science ®Google Scholar
• Sarode A, Fan Y, Byrnes AE, et al. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing. Nanoscale Adv. 2022 [cited 2022 Sep 20];4(9):2107–2123 doi:10.1039/D1NA00712B
   PubMed Web of Science ®Google Scholar
• Cui L, Pereira S, Sonzini S, et al. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery. Nanoscale. 2022 [cited 2022 Sep 20;]14(4):1480–1491 doi:10.1039/D1NR06858J
   PubMed Web of Science ®Google Scholar
• Fan Y, Shi Z, Ma S, et al. Spectroscopy-based local modeling method for high-throughput quantification of nucleic acid loading in lipid nanoparticles. Anal Chem. 2022 [cited 2022 Sep 20];94(25):9081–9090 doi:10.1021/acs.analchem.2c01346.
   PubMed Web of Science ®Google Scholar
• Ebeid K, Meng X, Thiel KW, et al. Synthetically lethal nanoparticles for treatment of endometrial cancer. Nat Nanotechnol. 2018 [cited 2021 Dec 15];13(1):72–81 doi:10.1038/s41565-017-0009-7
   PubMed Web of Science ®Google Scholar
• Fernandes E, Ferreira D, Peixoto A, et al. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential. Int J Pharm. 2019 [cited 2021 Dec 15];570:118646. doi: 10.1016/j.ijpharm.2019.118646
   PubMed Web of Science ®Google Scholar
• Wang X, Yang L, Zhang H, et al. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer. Colloids Surf B Biointerfaces. 2018 [cited 2021 Dec 15];172:708–717. doi: 10.1016/j.colsurfb.2018.09.033
   PubMed Web of Science ®Google Scholar
• Roces CB, Lou G, Jain N, et al. Manufacturing considerations for the development of lipid nanoparticles using microfluidics. Pharmaceutics. 2020 [cited 2021 Dec 26];12(11):1095 doi:10.3390/pharmaceutics12111095
   PubMed Web of Science ®Google Scholar
• Vu HTH, Streck S, Hook SM, et al. Utilization of microfluidics for the preparation of polymeric nanoparticles for the antioxidant rutin: a comparison with bulk production. Pharm Nanotechnol. 2019;7(6):469–483 doi:10.2174/2211738507666191019141049.
   PubMedGoogle Scholar
• Liu L, Bi M, Wang Y, et al. Artificial intelligence-powered microfluidics for nanomedicine and materials synthesis. Nanoscale. 2021 [cited 2022 Jul 15];13(46):19352–19366 doi:10.1039/D1NR06195J.
   PubMed Web of Science ®Google Scholar
• Streck S, Neumann H, Nielsen HM, et al. Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures. Int J Pharm X. 2019 [cited 2021 Dec 8];1:100030 doi:10.1016/j.ijpx.2019.100030.
   PubMedGoogle Scholar
• Bovone G, Steiner F, Guzzi EA, et al. Automated and continuous production of polymeric nanoparticles. Front Bioeng Biotechnol. 2019 [cited 2021 Nov 9];7:423. doi: 10.3389/fbioe.2019.00423
   PubMed Web of Science ®Google Scholar
• Tao H, Wu T, Kheiri S, et al. Self-driving platform for metal nanoparticle synthesis: combining microfluidics and machine learning. Adv Funct Mater. 2021 [cited 2022 Mar 6];31(51):2106725 doi:10.1002/adfm.202106725.
   Web of Science ®Google Scholar
• Loy DM, Krzysztoń R, Lächelt U, et al. Controlling nanoparticle formulation: a low-budget prototype for the automation of a microfluidic platform. Processes. 2021 [cited 2021 Dec 7];9(1):129 doi:10.3390/pr9010129
   Web of Science ®Google Scholar
• Tao H, Wu T, Aldeghi M, et al. Nanoparticle synthesis assisted by machine learning. Nat Rev Mater. 2021 [cited 2021 Sep 2];6(8):701–716 doi:10.1038/s41578-021-00337-5.
   Web of Science ®Google Scholar
• Bannigan P, Aldeghi M, Bao Z, et al. Machine learning directed drug formulation development. Adv Drug Deliv Rev. 2021 [cited 2021 Aug 31];175:113806. doi: 10.1016/j.addr.2021.05.016.
   PubMed Web of Science ®Google Scholar
• Bzdok D, Altman N, Krzywinski M. Statistics versus machine learning. Nat Methods. 2018 [cited 2021 Dec 30];15(4):233–234 doi:10.1038/nmeth.4642.
   PubMed Web of Science ®Google Scholar
• Vamathevan J, Clark D, Czodrowski P, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019 [cited 2021 Sep 4;]18(6):463–477 doi:10.1038/s41573-019-0024-5
   PubMed Web of Science ®Google Scholar
• Sarker IH. Machine learning: algorithms, real-world applications and research directions. SN Comput Sci. 2021 [cited 2022 Jan 20];2(3):160 doi:10.1007/s42979-021-00592-x.
   PubMedGoogle Scholar
• Damiati SA. Digital Pharmaceutical Sciences. AAPS PharmSciTech. 2020 [cited 2022 Mar 16];21(6):206 doi:10.1208/s12249-020-01747-4.
   PubMed Web of Science ®Google Scholar
• Häse F, Roch LM, Aspuru-Guzik A. Next-generation experimentation with self-driving laboratories. Trends Chem. 2019 [cited 2022 Feb 2];1(3):282–291 doi:10.1016/j.trechm.2019.02.007.
   Google Scholar
• Verma J, Khedkar VM, Coutinho EC. 3D-QSAR in drug design - A review. Curr Top Med Chem. 2010;10(1):95–115.
   PubMed Web of Science ®Google Scholar
• Suay-García B, Bueso-Bordils JI, Falcó A, et al. Virtual combinatorial chemistry and pharmacological screening: a short guide to drug design. Int J Mol Sci. 2022 [cited 2022 Mar 26];23(3):1620 doi:10.3390/ijms23031620
   PubMed Web of Science ®Google Scholar
• Mao J, Akhtar J, Zhang X, et al. Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models. iScience. 2021 [cited 2022 May 2];24(9):103052 doi:10.1016/j.isci.2021.103052.
   PubMed Web of Science ®Google Scholar
• Tsou LK, Yeh S-H, Ueng S-H, et al. Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Sci Rep. 2020 [cited 2022 May 2];10(1):16771 doi:10.1038/s41598-020-73681-1
   PubMed Web of Science ®Google Scholar
• Chakravarti SK, Alla SRM. Descriptor free QSAR modeling using deep learning with long short-term memory neural networks. Front Artif Intell. 2019. [cited 2022 May 7];2 17 doi:10.3389/frai.2019.00017 7 May. .
   PubMedGoogle Scholar
• Sason H, Shamay Y. Nanoinformatics in drug delivery. Isr J Chem. 2020 [cited 2022 Jul 24];60(12):1108–1117 doi:10.1002/ijch.201900042.
   Web of Science ®Google Scholar
• Jones DE, Ghandehari H, Facelli JC. A review of the applications of data mining and machine learning for the prediction of biomedical properties of nanoparticles. Comput Methods Programs Biomed. 2016 [cited 2021 Dec 14];132:93–103. doi: 10.1016/j.cmpb.2016.04.025
   PubMed Web of Science ®Google Scholar
• Singh AV, Rosenkranz D, Ansari MHD, et al. Artificial intelligence and machine learning empower advanced biomedical material design to toxicity prediction. Adv Intell Syst. 2020 [cited 2022 Mar 6];2(12):2000084 doi:10.1002/aisy.202000084
   Google Scholar
• Youshia J, Ali ME, Lamprecht A. Artificial neural network based particle size prediction of polymeric nanoparticles. Eur J Pharm Biopharm. 2017 [cited 2021 Dec 29];119:333–342. doi: 10.1016/j.ejpb.2017.06.030
   PubMed Web of Science ®Google Scholar
• Asadi H, Rostamizadeh K, Salari D, et al. Preparation of biodegradable nanoparticles of tri-block PLA––PEG––PLA copolymer and determination of factors controlling the particle size using artificial neural network. J Microencapsul. 2011 [cited 2021 Dec 14];28(5):406–416 doi:10.3109/02652048.2011.576784
   PubMed Web of Science ®Google Scholar
• He Y, Ye Z, Liu X, et al. Can machine learning predict drug nanocrystals? J Control Release. 2020 [cited 2022 Mar 6];322:274–285. doi: 10.1016/j.jconrel.2020.03.043
   PubMed Web of Science ®Google Scholar
• Gao H, Wang W, Dong J, et al. An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design. Eur J Pharm Biopharm. 2021 [cited 2022 Mar 10];158:336–346. doi: 10.1016/j.ejpb.2020.12.001
   PubMed Web of Science ®Google Scholar
• Cai C, Wang S, Xu Y, et al. Transfer learning for drug discovery. J Med Chem. 2020 [cited 2022 Sep 29];63(16):8683–8694 doi:10.1021/acs.jmedchem.9b02147.
   PubMed Web of Science ®Google Scholar
• Huang L, Ling C. Leveraging transfer learning and chemical principles toward interpretable materials properties. J Chem Inf Model. 2021 [cited 2022 Sep 29];61(9):4200–4209 doi:10.1021/acs.jcim.1c00434.
   PubMed Web of Science ®Google Scholar
• Smith JS, Nebgen BT, Zubatyuk R, et al. Approaching coupled cluster accuracy with a general-purpose neural network potential through transfer learning. Nat Commun. 2019 [ited 2022 Sep 29];10(1):2903 doi:10.1038/s41467-019-10827-4
   PubMedGoogle Scholar
• Wiercioch M, Kirchmair J. Dealing with a data-limited regime: combining transfer learning and transformer attention mechanism to increase aqueous solubility prediction performance. Artif Intell Life Sci. 2021 [cited 2021 Dec 7];1:100021 doi:10.1016/j.ailsci.2021.100021.
   Google Scholar
• Sanchez-Lengeling B, Aspuru-Guzik A. Inverse molecular design using machine learning: generative models for matter engineering. Science. 2018 [cited 2021 Oct 14];361(6400):360–365 doi:10.1126/science.aat2663.
   PubMed Web of Science ®Google Scholar
• Kusne AG, Yu H, Wu C, et al. On-the-fly closed-loop materials discovery via Bayesian active learning. Nat Commun. 2020 [cited 2022 Jan 3];11(1):5966 doi:10.1038/s41467-020-19597-w
   PubMed Web of Science ®Google Scholar
• Kumar JN, Li Q, Tang KYT, et al. Machine learning enables polymer cloud-point engineering via inverse design. Npj Comput Mater. 2019 [cited 2021 Dec 14];5(1):1–6 doi:10.1038/s41524-019-0209-9
   Google Scholar
• Mekki-Berrada F, Ren Z, Huang T, et al. Two-step machine learning enables optimized nanoparticle synthesis. Npj Comput Mater. 2021 [cited 2021 Dec 14];7(1):1–10 doi:10.1038/s41524-021-00520-w
   Web of Science ®Google Scholar
• Kumar R, Le N, Tan Z, et al. Efficient polymer-mediated delivery of gene-editing ribonucleoprotein payloads through combinatorial design, parallelized experimentation, and machine learning. ACS Nano. 2020;14(12):17626–17639 doi:10.1021/acsnano.0c08549.
   PubMed Web of Science ®Google Scholar
• Yamankurt G, Berns EJ, Xue A, et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat Biomed Eng. 2019 [cited 2021 Dec 29];3(4):318–327 doi:10.1038/s41551-019-0351-1
   PubMed Web of Science ®Google Scholar
• Stein H S, Gregoire J M. Progress and prospects for accelerating materials science with automated and autonomous workflows. Chem Sci.. 2019 [cited 2022 Sep 29];10(42):9640–9649 doi:10.1039/C9SC03766G.
   PubMed Web of Science ®Google Scholar
• Stach E, DeCost B, Kusne AG, et al. Autonomous experimentation systems for materials development: a community perspective. Matter. 2021 [cited 2022 Sep 29];4(9):2702–2726 doi:10.1016/j.matt.2021.06.036
   Google Scholar
• Nambiar AMK, Breen CP, Hart T, et al. Bayesian optimization of computer-proposed multistep synthetic routes on an automated robotic flow platform. ACS Cent Sci. 2022 [cited 2022 Sep 29];8(6):825–836 doi:10.1021/acscentsci.2c00207.
   PubMed Web of Science ®Google Scholar
• Shields BJ, Stevens J, Li J, et al. Bayesian reaction optimization as a tool for chemical synthesis. Nature. 2021 [cited 2022 Sep 29];590(7844):89–96 doi:10.1038/s41586-021-03213-y
   PubMed Web of Science ®Google Scholar
• Baumgartner LM, Coley CW, Reizman BJ, et al. Optimum catalyst selection over continuous and discrete process variables with a single droplet microfluidic reaction platform. React Chem Eng. 2018 [cited 2022 Sep 29];3(3):301–311 doi:10.1039/C8RE00032H
   Web of Science ®Google Scholar
• Cortés-Borda D, Wimmer E, Gouilleux B, et al. An autonomous self-optimizing flow reactor for the synthesis of natural product carpanone. J Org Chem. 2018 [cited 2022 Sep 29];83(23):14286–14299 doi:10.1021/acs.joc.8b01821.
   PubMed Web of Science ®Google Scholar
• Xue D, Balachandran PV, Hogden J, et al. Accelerated search for materials with targeted properties by adaptive design. Nat Commun. 2016 [cited 2022 Sep 29];7(1):11241 doi:10.1038/ncomms11241
   PubMedGoogle Scholar
• Nikolaev P, Hooper D, Webber F, et al. Autonomy in materials research: a case study in carbon nanotube growth. Npj Comput Mater. 2016 [cited 2022 Sep 29];2(1):1–6 doi:10.1038/npjcompumats.2016.31
   Google Scholar
• Rohr B, Stein HS, Guevarra D, et al. Benchmarking the acceleration of materials discovery by sequential learning. Chem Sci. 2020 [cited 2022 Sep 29];11(10):2696–2706 doi:10.1039/C9SC05999G
   PubMed Web of Science ®Google Scholar
• Burger B, Maffettone PM, Gusev VV, et al. A mobile robotic chemist. Nature. 2020 [cited 2022 Sep 29];583(7815):237–241 doi:10.1038/s41586-020-2442-2
   PubMed Web of Science ®Google Scholar
• Crabtree G. Self-driving laboratories coming of age. Joule. 2020 [cited 2022 Feb 2];4(12):2538–2541 doi:10.1016/j.joule.2020.11.021.
   Web of Science ®Google Scholar
• Bian Y, Xie X-Q. Generative chemistry: drug discovery with deep learning generative models. J Mol Model. 2021 [cited 2022 Feb 3];27(3):71 doi:10.1007/s00894-021-04674-8.
   PubMed Web of Science ®Google Scholar
• Butakova MA, Chernov AV, Kartashov OO, et al. Data-centric architecture for self-driving laboratories with autonomous discovery of new nanomaterials. Nanomaterials. 2021 [cited 2022 Feb 2];12(1):12 doi:10.3390/nano12010012
   Web of Science ®Google Scholar
• Tamasi MJ, Patel RA, Borca CH, et al. Machine learning on a robotic platform for the design of polymer–protein hybrids. Adv Mater. 2022 [cited 2022 Sep 22];34(30):2201809 doi:10.1002/adma.202201809.
   Web of Science ®Google Scholar
• Dalal R, Leyden M, Oviedo F, et al. Polymer design via SHAP and bayesian machine learning optimizes pDNA and CRISPR ribonucleoprotein delivery [Internet]. Research Square; 2022 [cited 2022 Sep 20]. Available from: https://www.researchsquare.com/article/rs-1785891/v1.
   Google Scholar
• Wang S, Shen Z, Shen Z, et al. Machine-learning micropattern manufacturing. Nano Today. 2021 [cited 2022 Jul 16];38:101152. doi:10.1016/j.nantod.2021.101152
   Web of Science ®Google Scholar
• Villa Nova M, Lin TP, Shanehsazzadeh S, et al. Nanomedicine ex machina: between model-informed development and artificial intelligence. Front Digit Health. 2022 [cited 2022 Apr 10];4:799341. doi: 10.3389/fdgth.2022.799341
   PubMedGoogle Scholar
• Serov N, Vinogradov V. Artificial intelligence to bring nanomedicine to life. Adv Drug Deliv Rev. 2022 [cited 2022 Jul 24];184:114194. doi:10.1016/j.addr.2022.114194
   PubMed Web of Science ®Google Scholar
• Chen C, Yaari Z, Apfelbaum E, et al. Merging data curation and machine learning to improve nanomedicines. Adv Drug Deliv Rev . 2022 [cited 2022 Jul 24];183:114172. doi: 10.1016/j.addr.2022.114172
   PubMed Web of Science ®Google Scholar
• Ong JJ, Castro BM, Gaisford S, et al. Accelerating 3D printing of pharmaceutical products using machine learning. Int J Pharm X. 2022 [cited 2022 Sep 20];4:100120. doi: 10.1016/j.ijpx.2022.100120
   PubMedGoogle Scholar
• Zhou T, Song Z, Sundmacher K. Big data creates new opportunities for materials research: a review on methods and applications of machine learning for materials design. Engineering. 2019 [cited 2021 Dec 14];5(6):1017–1026. doi:10.1016/j.eng.2019.02.011
   Web of Science ®Google Scholar
• Hayat H, Nukala A, Nyamira A, et al. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine. Biomed Mater. 2021 [cited 2022 Jul 24];16(5):052001. doi:10.1088/1748-605X/ac15b2
   Web of Science ®Google Scholar
• Singh AV, Ansari MHD, Rosenkranz D, et al. Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine. Adv Healthc Mater. 2020 [cited 2022 Mar 6];9(17):1901862. doi:10.1002/adhm.201901862
   Web of Science ®Google Scholar
• Singh AV, Maharjan R-S, Kanase A, et al. Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells. ACS Appl Mater Interfaces. 2021 [cited 2022 Jul 24];13(1):1943–1955. doi:10.1021/acsami.0c18470
   PubMed Web of Science ®Google Scholar
• Jia Y, Hou X, Wang Z, et al. Machine learning boosts the design and discovery of nanomaterials. ACS Sustain Chem Eng. 2021 [cited 2022 Jul 29];9(18):6130–6147. doi:10.1021/acssuschemeng.1c00483
   Web of Science ®Google Scholar
• Zhang C, Mou M, Zhou Y, et al. Biological activities of drug inactive ingredients. Brief Bioinform. 2022 [cited 2022 Jun 6];23(5):bbac160. doi:10.1093/bib/bbac160
   PubMed Web of Science ®Google Scholar
• Rebollo R, Oyoun F, Corvis Y, et al. Microfluidic manufacturing of liposomes: development and optimization by design of experiment and machine learning. ACS Appl Mater Interfaces. 2022 [cited 2022 Sep 20];14(35):39736–39745. doi:10.1021/acsami.2c06627
   PubMedGoogle Scholar
• Schmitt JM, Baumann JM, Morgen MM. Predicting spray dried dispersion particle size via machine learning regression methods. Pharm Res. 2022 [cited 2022 Sep 20];39(12):3223–3239. doi:10.1007/s11095-022-03370-3
   PubMed Web of Science ®Google Scholar
• Yoo S, Kim J, Choi GJ. Drug properties prediction based on deep learning. Pharmaceutics. 2022 [cited 2022 Jun 6];14(2):467. doi:10.3390/pharmaceutics14020467
   PubMed Web of Science ®Google Scholar
• Basso J, Mendes M, Cova T, et al. A stepwise framework for the systematic development of lipid nanoparticles. Biomolecules. 2022 [cited 2022 Jun 6];12(2):223. doi:10.3390/biom12020223
   PubMed Web of Science ®Google Scholar
• Li J, Gao H, Ye Z, et al. In silico formulation prediction of drug/cyclodextrin/polymer ternary complexes by machine learning and molecular modeling techniques. Carbohydr Polym . 2022 [cited 2022 Mar 6];275:118712. doi: 10.1016/j.carbpol.2021.118712
   PubMed Web of Science ®Google Scholar
• Liu W, Zhao R, Su X, et al. Development and validation of machine learning models for prediction of nanomedicine solubility in supercritical solvent for advanced pharmaceutical manufacturing. J Mol Liq . 2022 [cited 2022 Jul 24];358:119208. doi: 10.1016/j.molliq.2022.119208
   Web of Science ®Google Scholar
• Lin Z, Chou W-C, Cheng Y-H, et al. Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches. Int J Nanomedicine . 2022 [cited 2022 Jul 24];17:1365–1379. doi: 10.2147/IJN.S344208
   PubMed Web of Science ®Google Scholar
• Wang W, Feng S, Ye Z, et al. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm. Acta Pharm Sin B. 2022 [cited 2022 Jul 24];12(6):2950–2962. doi:10.1016/j.apsb.2021.11.021
   PubMed Web of Science ®Google Scholar
• Gao H, Kan S, Ye Z, et al. Development of in silico methodology for siRNA lipid nanoparticle formulations. Chem Eng J. 2022 [cited 2022 Jul 24];442:136310. doi: 10.1016/j.cej.2022.136310
   Google Scholar
• Başkor A, Tok YP, Mesut B, et al. Estimating the optimal dexketoprofen pharmaceutical formulation with machine learning methods and statistical approaches. Healthc Inform Res. 2021 [c]ited 2022 Jun 22;27(4):279–286 doi:10.4258/hir.2021.27.4.279
   PubMed Web of Science ®Google Scholar
• Ye Z, Ouyang D. Prediction of small-molecule compound solubility in organic solvents by machine learning algorithms. J Cheminformatics. 2021 [cited 2022 Jul 24];13(1):98 doi:10.1186/s13321-021-00575-3
   PubMed Web of Science ®Google Scholar
• Dong J, Gao H, Ouyang D. PharmSD: a novel AI-based computational platform for solid dispersion formulation design. Int J Pharm. 2021 [cited 2022 Mar 16];604 doi:10.1016/j.ijpharm.2021.120705
   Google Scholar
• Hathout RM, Mahmoud OA, Ali DS, et al. Modeling drugs-PLGA nanoparticles interactions using gaussian processes: pharmaceutics informatics approach. J Clust Sci. 2021 [cited 2021 Dec 30]. doi: 10.1007/s10876-021-02126-0
   PubMed Web of Science ®Google Scholar
• Duan Y, Coreas R, Liu Y, et al. Prediction of protein Corona on nanomaterials by machine learning using novel descriptors. NanoImpact. 2020 [cited 2022 Jul 29];17:100207. doi: 10.1016/j.impact.2020.100207
   Web of Science ®Google Scholar
• Ban Z, Yuan P, Yu F, et al. Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles. Proc Natl Acad Sci. 2020 [cited 2022 Aug 29];117(19):10492–10499 doi:10.1073/pnas.1919755117
   PubMed Web of Science ®Google Scholar
• Gill J, Moullet M, Martinsson A, et al. Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug–drug interaction prediction. CPT Pharmacomet Syst Pharmacol. [cited 2022 Dec 3];11(12):1560–1568 doi:10.1002/psp4.12870
   PubMedGoogle Scholar